FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagefhir.ke.nccp
Resource TypeClaim
IdClaim-OncologyClaimExample.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

SHA insurance claim for Doxorubicin + Cyclophosphamide (AC) cycle 1 session 1 for breast cancer


Source1

{
  "resourceType": "Claim",
  "id": "OncologyClaimExample",
  "meta": {
    "profile": [
      "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-oncology-claim"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-carcinoma-staging-extension",
      "valueCode": "STAGE-2"
    },
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-treatment-setting-extension",
      "valueCode": "DAY-CASE"
    },
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-session-expected-date-extension",
      "valueDate": "2026-01-15"
    },
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-sessions-required-extension",
      "valueInteger": 8
    },
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cost-per-session-extension",
      "valueMoney": {
        "value": 15000,
        "currency": "KES"
      }
    },
    {
      "url": "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-regimen-reference-extension",
      "valueReference": {
        "reference": "CarePlan/example-careplan"
      }
    }
  ],
  "status": "active",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/claim-type",
        "code": "professional",
        "display": "Professional"
      }
    ]
  },
  "use": "preauthorization",
  "patient": {
    "reference": "Patient/example-patient"
  },
  "created": "2026-01-15",
  "provider": {
    "reference": "Organization/example-organization"
  },
  "priority": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/processpriority",
        "code": "normal",
        "display": "Normal"
      }
    ]
  },
  "diagnosis": [
    {
      "sequence": 1,
      "diagnosisReference": {
        "reference": "Condition/example-condition"
      }
    }
  ],
  "insurance": [
    {
      "sequence": 1,
      "focal": true,
      "coverage": {
        "reference": "Coverage/example-coverage"
      }
    }
  ],
  "item": [
    {
      "sequence": 1,
      "productOrService": {
        "coding": [
          {
            "system": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
            "code": "SHA-CHEMO-NEO-ADJUVANT",
            "display": "SHA: Chemotherapy — Neo-adjuvant"
          }
        ]
      },
      "quantity": {
        "value": 1
      },
      "unitPrice": {
        "value": 15000,
        "currency": "KES"
      },
      "detail": [
        {
          "sequence": 1,
          "productOrService": {
            "coding": [
              {
                "system": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
                "code": "SHA-CHEMO-NEO-ADJUVANT",
                "display": "SHA: Chemotherapy — Neo-adjuvant"
              }
            ]
          },
          "quantity": {
            "value": 1
          },
          "unitPrice": {
            "value": 7500,
            "currency": "KES"
          }
        }
      ]
    }
  ]
}